Skip to main content

Rejected Lancet Correspondence: Reducing Meat Consumption by Intensifying Public Awareness

The following rejected correspondence was written in respond to the editorial published in the Lancet

Title: Reducing Meat Consumption by Intensifying Public Awareness

 Vivek Podder; Md. Ferdous Rahman


The Lancet editorial (November 24, p 508)1 highlighted impact of increasing meat consumption on ecological sustainability and consumers’ health. The growing demand of meat from increasing population and consequent increase in their production can be mitigated by taxing red and processed meat, reducing their consumption. We would like to specify one missing aspect to this debate. 

Missing from this debate, however, is the public awareness of the health and environmental impact of meat and attitudes to reduce their consumption as studied by Clonan and their colleagues. [2] Public perception of meat as healthy food could limit their meat consumption as reflected in the UK dietary guidelines stating, “meat is a good source of protein in your diet, as well as vitamins and minerals”.2

Promotion of conscious behavioral changes and intensifying awareness of meat consumption risks may benefit population health by subsequently reducing their consumption. Studies have found informational campaigns targeting specific consumer groups are effective in increasing awareness and promoting knowledge about the balanced products, which can substitute meat.3 This will also require taking individual social and cultural contests into account as studied by Macdiarmid and their colleagues.4 

To attain this, we need better understanding of the factors and beliefs that motivate people to consume more meat. When these factors are identified, effective interventions can be designed for specific populations. Therefore, healthcare professionals, nutritionists and policy makers should work together in developing dietary guidelines that balance our eating desire with the need to preserve sustainable ecosystem.


1. The Lancet. We need to talk about meat. Lancet 2018; 392: 2237.
2. Clonan A, Wilson P, Swift JA, Leibovici DG, Holdsworth M. Red and processed meat consumption and purchasing behaviours and attitudes: impacts for human health, animal welfare and environmental sustainability. Public Health Nutr 2015; 18(13):2446-56.
3. Silva C, Manzano FP. Environmental and Health Cost of Meat: How to Reduce Consumption? JSM Nutr Disord 2017; 1(1): 1004.
4. Macdiarmid JI, Douglas F, Campbell J. Eating like there's no tomorrow: Public awareness of the environmental impact of food and reluctance to eat less meat as part of a sustainable diet 2016. Appetite; 96:487-93.

Comments

Popular posts from this blog

55 years Old male with Bipolar affected disorder moving from depression to Manic to depression phase

Disclaimer:- This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here December 2017 after collecting informed patient consent (form downloadable Click Here) This is a case of a 55 years old, diabetic, hypertensive patient who was diagnosed with Bipolar affected disorder since 1995. In 1995 due to financial loss he was attacked by this condition. He was seen by Dr. D. K Agarwala and diagnosed as BPAD-Depression phase and treated with lithium, sodium valporate, propranolol, Zeptol cr, Nitrosum - S.  With the treatment he was reasonably well but every 6 months of interval he appeared to have some disturbance like didn't want to talk to anybody, forgot to smile etc. They went to the doctor and treated accordingly and was continuing the treatment.  In the year of 2013, August he was diagnosed with BPAD-severe depression phase but, he was not responding well to the medications and then they went to NIMHANS for

Consent Forms

Hindi BMJ Consent form   Bengali BMJ Consent form English BMJ Consent form   Telegu BMJ Consent Form Telegu BMJ Consent Form   UDHC Consent Form                

drugs to avoid or use in terms of their pregnancy category

The optimal AEDs therapy of women with epilepsy who are of childbearing age is unclear because of a lack of conclusive data on the comparative teratogenicity of different antiseizure drugs and no antiepileptic drug has proven safe in pregnancy in terms of teratogenesis. Data on the comparative efficacy of various antiseizure drugs for controlling seizures during pregnancy are also quite limited, and there are no randomized trials in this setting. Treatment must be individualized for all patients. Women with epilepsy are classified as high risk during pregnancy and as there are no clear data indicating that any drug is without risk in pregnancy therefore, the antiseizure drug regimen should be optimized six months prior to planned conception.  Choice of antiepileptic drugs in women of childbearing age and  pregnant women with epilepsy:  1. T he antiseizure drug that stops seizures in a given patient is the one that should be used with an exception of valproate. 2.